Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the safety and efficacy of nemtabrutinib (formerly ARQ 531) in participants with hematologic malignancies of chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and Waldenström's macroglobulinemia (WM).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent w dobrym stanie ogólnym (może wykonywać większość codziennych czynności)
- •Spodziewana długość życia co najmniej 3 miesiące
- •Możliwość łykania i przyjmowania leków doustnych
- •Prawidłowa funkcja organów wewnętrznych
- •Pacjenci z zapaleniem wątroby B lub C mogą uczestniczyć, jeśli są leceni i wirus jest w kontroli
- •Pacjenci z HIV mogą uczestniczyć, jeśli przyjmują leki antyretrowirusowe i wirus jest w kontroli
- •Zdolność do stosowania antykoncepcji lub rezygnacji z aktywności seksualnej podczas badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (121)
Highlands Oncology Group ( Site 2728)
Springdale, United States
University of California San Diego Moores Cancer Center ( Site 2717)
La Jolla, United States
Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724)
Torrance, United States
Colorado Blood Cancer Institute ( Site 2726)
Denver, United States
The University of Louisville, James Graham Brown Cancer Center ( Site 2729)
Louisville, United States
Mayo Clinic - Rochester ( Site 2706)
Rochester, United States
Astera Cancer Care ( Site 2732)
East Brunswick, United States
John Theurer Cancer Center at Hackensack University Medical Center ( Site 2704)
Hackensack, United States
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 2708)
Fargo, United States
UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730)
Dallas, United States
Medical Oncology Associates (Summit Cancer Centers) ( Site 2710)
Spokane, United States
Hospital Aleman ( Site 0102)
Ciudad Autonoma de Buenos Aires, Argentina
Centro de Educación Médica e Investigaciones Clínicas (CEMIC) ( Site 0103)
Buenos Aires, Argentina
Fundacion Estudios Clinicos ( Site 0112)
Rosario, Argentina
FUNDALEU ( Site 0104)
Caba, Argentina
Hospital Privado Universitario de Córdoba ( Site 0107)
Córdoba, Argentina
Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0110)
Mendoza, Argentina
Nepean Hospital-Nepean Cancer Care Centre ( Site 0204)
Sydney, Australia
Box Hill Hospital ( Site 0203)
Box Hill, Australia
Sir Charles Gairdner Hospital ( Site 0200)
Nedlands, Australia
Hospital das Clinicas FMUSP-Pesquisa Clínica Hematologia ( Site 0303)
São Paulo, Brazil
Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0300)
Rio de Janeiro, Brazil
BP - A Beneficencia Portuguesa de São Paulo ( Site 0302)
São Paulo, Brazil
Hospital Paulistano - Amil Clinical Research ( Site 0311)
São Paulo, Brazil
Arthur J.E. Child Comprehensive Cancer Centre ( Site 0401)
Calgary, Canada
The Ottawa Hospital ( Site 0404)
Ottawa, Canada
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0406)
Toronto, Canada
CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0403)
Montreal, Canada
Département clinique de médecine de laboratoire du CHUM ( Site 0400)
Montreal, Canada
Anhui Provincial Hospital ( Site 2808)
Hefei, China
Peking University Third Hospital-Hematology ( Site 2827)
Beijing, China
The Second Affiliated Hospital of Chongqing Medical University ( Site 2825)
Chongqing, China
Sun Yat-sen University Cancer Center-Internal Medicine ( Site 2824)
Guangzhou, China
Liuzhou People's Hospital ( Site 2817)
Liuzhou, China
Guangxi Medical University Cancer Hospital ( Site 2814)
Nanning, China
Henan Cancer Hospital-hematology department ( Site 2802)
Zhengzhou, China
Wuhan Union Hospital ( Site 2816)
Wuhan, China
The Second Xiangya Hospital of Central South University ( Site 2820)
Changsha, China
Hunan Cancer Hospital ( Site 2822)
Changsha, China
Jiangsu Province Hospital ( Site 2823)
Nanjing, China
The Affiliated Hospital of Xuzhou Medical College ( Site 2818)
Xuzhou, China
The First Affiliated Hospital of Nanchang University ( Site 2815)
Nanchang, China
The First Hospital of Jilin University-Hematology ( Site 2803)
Changchun, China
Fudan University Shanghai Cancer Center ( Site 2801)
Shanghai, China
Huashan Hospital, Fudan University ( Site 2821)
Shanghai, China
West China Hospital Sichuan University ( Site 2810)
Chengdu, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Unio ( Site 2800)
Tianjin, China
The First Affiliated Hospital, Zhejiang University ( Site 2826)
Hangzhou, China
Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0600)
Brno, Czechia
Fakultni nemocnice Hradec Kralove ( Site 0601)
Hradec Králové, Czechia
Aarhus University Hospital ( Site 0702)
Aarhus N, Denmark
Aalborg Universitetshospital ( Site 0703)
Aalborg, Denmark
Sjaellands Universitetshospital Roskilde ( Site 0701)
Roskilde, Denmark
Odense University Hospital ( Site 0705)
Odense C, Denmark
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 0810)
Nice, France
Centre Hospitalier Lyon-Sud ( Site 0804)
Pierre-Bénite, France
Institut Paoli-Calmettes ( Site 0803)
Marseille, France
Centre Hospitalier de Versailles ( Site 0809)
Le Chesnay, France
Hopital Saint Louis ( Site 0805)
Paris, France
Universitaetsklinikum Ulm. ( Site 0906)
Ulm, Germany
Universitaetsklinikum Koeln ( Site 0901)
Cologne, Germany
St. Marien-Krankenhaus Siegen ( Site 0914)
Siegen, Germany
Universitaetsklinikum Carl Gustav Carus ( Site 0902)
Dresden, Germany
Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar ( Site 1202)
Pécs, Hungary
Debreceni Egyetem Klinikai Kozpont ( Site 1201)
Debrecen, Hungary
Szabolcs Szatmár Bereg Vármegyei Oktatókórház ( Site 1206)
Nyíregyháza, Hungary
Orszagos Onkologiai Intezet ( Site 1200)
Budapest, Hungary
Beaumont Hospital ( Site 2900)
Dublin, Ireland
University Hospital Limerick ( Site 2903)
Limerick, Ireland
Ha Emek Medical Center ( Site 1305)
Afula, Israel
Soroka Medical Center ( Site 1307)
Beersheba, Israel
Rambam Medical Center ( Site 1301)
Haifa, Israel
Hadassah Ein Karem Jerusalem ( Site 1300)
Jerusalem, Israel
Chaim Sheba Medical Center ( Site 1302)
Ramat Gan, Israel
Kaplan Medical Center ( Site 1304)
Rehovot, Israel
Sourasky Medical Center ( Site 1303)
Tel Aviv, Israel
Istituto Tumori Giovanni Paolo II ( Site 1409)
Bari, Italy
A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1400)
Bologna, Italy
ASST Spedali Civili di Brescia ( Site 1408)
Brescia, Italy
IRCCS Ospedale San Raffaele ( Site 1402)
Milan, Italy
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1403)
Naples, Italy
Fondazione IRCCS Policlinico San Matteo ( Site 1407)
Pavia, Italy
IRCCS - Arcispedale Santa Maria Nuova ( Site 1405)
Reggio Emilia, Italy
Policlinico Umberto I ( Site 1404)
Roma, Italy
Pratia MCM Krakow ( Site 1601)
Krakow, Poland
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu ( Site 1606)
Wroclaw, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1608)
Warsaw, Poland
Szpital Wojewódzki w Opolu-Hematology Department ( Site 1607)
Opole, Poland
Szpitale Pomorskie Sp. z o.o. ( Site 1600)
Gdynia, Poland
Spitalul Clinic Colțea ( Site 1805)
Bucharest, Romania
Ovidius Clinical Hospital ( Site 1804)
Ovidiu, Romania
Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 1802)
Brasov, Romania
Institutul Regional de Oncologie Iasi ( Site 1801)
Iași, Romania
Severance Hospital Yonsei University Health System ( Site 2201)
Seoul, South Korea
Samsung Medical Center ( Site 2200)
Seoul, South Korea
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 2000)
L'Hospitalet de Llobregat, Spain
Hospital Universitario de Salamanca ( Site 2002)
Salamanca, Spain
CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2005)
A Coruña, Spain
Hospital General Universitario de Alicante ( Site 2007)
Alicante, Spain
Hospital Universitari Vall d'Hebron ( Site 2001)
Barcelona, Spain
Hospital Universitario 12 de Octubre ( Site 2003)
Madrid, Spain
Hospital Puerta de Hierro ( Site 2009)
Madrid, Spain
Inselspital Bern ( Site 2303)
Bern, Switzerland
Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 2302)
Bellinzona, Switzerland
Mega Medipol-Hematology ( Site 2406)
Stanbul, Turkey (Türkiye)
Ankara Universitesi Tip Fakultesi Cebeci Hastanesi ( Site 2400)
Ankara, Turkey (Türkiye)
VKV Amerikan Hastanesi ( Site 2403)
Istanbul, Turkey (Türkiye)
Sisli Florence Nightingale Hastanesi ( Site 2407)
Istanbul, Turkey (Türkiye)
Dokuz Eylül Üniversitesi-Hematology ( Site 2402)
Izmir, Turkey (Türkiye)
MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2509)
Cherkassy, Ukraine
Communal non-profit enterprise "Regional clinical hospital o-Hematology Department ( Site 2510)
Ivano-Frankivsk, Ukraine
Instit. of Blood Transfusion Medicine of the National Academy ( Site 2506)
Lviv, Ukraine
National Cancer Institute ( Site 2507)
Kyiv, Ukraine
Bristol Haematology and Oncology Centre ( Site 2610)
Bristol, United Kingdom
Nottingham University Hospitals NHS Trust. City Hospital Campus ( Site 2601)
Nottingham, United Kingdom
GenesisCare - Windsor ( Site 2608)
Windsor, United Kingdom
Sarah Cannon Research Institute UK ( Site 2612)
London, United Kingdom
GenesisCare - Oxford ( Site 2607)
Oxford, United Kingdom
GenesisCare - Cambridge ( Site 2611)
Newmarket, United Kingdom
The Royal Marsden NHS Foundation Trust. ( Site 2606)
Sutton, United Kingdom
The Christie NHS Foundation Trust ( Site 2602)
Manchester, United Kingdom
Trial contact
Toll Free Number
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/21/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.